Fly News Breaks for February 15, 2019
Feb 15, 2019 | 07:24 EDT
Bernstein analyst Christian Bolu reiterated an Outperform rating on CME Group but lowered his price target to $210 following the company's Q4 results. In a research note to investors, Bolu says CME stock has underperformed YTD in sync with softer activity trends, but believes the print should help reset expectations and provide a better setup for stock price outperformance.
News For CME From the Last 2 Days
There are no results for your query CME